Document is current
Any future updates will be listed below
-
Authors
Stalinska, Joanna
Vittori, Cecilia
Ingraham IV, Charles H.
Carson, Sean C.
Plaisance-Bonstaff, Karlie
Lassak, Adam
Faia, Celeste
Colley, Susan B.
Peruzzi, Francesca
Reiss, Krzysztof
Jursic, Branko S.
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (1 P20 GM121288)
- License Information
-
More Information
Article History
Received: 15 September 2021
Accepted: 14 February 2022
First Online: 1 March 2022
Competing interests
: Disclosure of Potential Conflict of Interest: Dr. Branko Jursic is associated with Stepharm LLC, P.O. Box 24220, New Orleans, LA; Dr. Reiss is associated with WayPath Pharma LLC. 217 Sena Dr. Metairie LA 70005. Dr. Krzysztof Reiss and Dr. Branko Jursic have LSU patent for the HR compounds presented in this manuscript ("Anticancer Composition and methods of use" WO2020/146876. Other authors do not have any competing interest in relation to this submission.
